Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta-Analysis

Introduction: The therapeutic impact of molnupiravir in the Omicron variant phase is unknown. The goal of the current meta-analysis was to compare the real-world clinical outcomes of molnupiravir for the treatment of mild to moderate COVID-19 during the dominance of the Omicron variant in adult pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chienhsiu, Lu, Tsung-Lung, Lin, Lichen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952148/
https://www.ncbi.nlm.nih.gov/pubmed/36830302
http://dx.doi.org/10.3390/antibiotics12020393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952148/
https://www.ncbi.nlm.nih.gov/pubmed/36830302
http://dx.doi.org/10.3390/antibiotics12020393

Ejemplares similares